E&S Healthcare promises a healthier life for mankind.
The current gold standard of early detection of breast cancer
is mammography that has inevitable weak points such as cost, discomfort, and
radiation exposure. Besides, an additional examination might be necessary for
better diagnosis of dense breasts.
Our breast cancer diagnostic kit, DxMe® BC, measures a specific
protein biomarker from the blood by ELISA regardless of breast conditions. It
can help detect breast cancer exactly. The accuracy can be maximally enhanced
when it is accompanied with mammography.
Item | Particular |
---|---|
Test Format | Sandwich ELISA |
Brand Name | DxMe® BC Kit |
Specificity | 96.43%1 |
Sensitivity | 97.32%1 |
Cut-off | 11.4 ng/ml1 |
99% Reference range | 3.4 ~ 18.8ng/ml |
Detection Range | 3.4 ~ 44.4ng/ml |
Tests per kit | 88 Tests |
QMS Certificates | ISO 13485 KGMP BGMP |
Product registration | European union Malaysia Serbia New Zealand |
Stability | ≤ 12 months (at 4℃) |
(As of 2017)